Compare Medpace Holdings Inc (MEDP) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.

VXUS, the Vanguard Total International Stock ETF, trades at $87.54, up 0.82% today. The technical outlook is bullish based on moving averages, though oscillators are neutral and RSI levels suggest potential overbought conditions. Recent news highlights strong institutional buying and a 27.82% total return over the past year, emphasizing its role in diversifying beyond U.S. equities at a valuation discount.

The outlook for VXUS is positive, driven by international diversification benefits and strong recent performance. Key risks include global economic sensitivity and potential inflation impacts. Analyst sentiment is generally favorable, with institutional accumulation supporting long-term growth potential for investors seeking broad non-U.S. market exposure.